Pliant Therapeutics Inc
PLRX
Market Cap$734.32M
Close$
$0.84
93.3% downside
Current Fair Value
93.3% downsideOvervalued by 93.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $734.32 Million |
|---|---|
| Enterprise Value | $251.44 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.75 |
| Beta | 0.87 |
| Outstanding Shares | 60,239,176 |
| Avg 30 Day Volume | 306,316 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.55 |
|---|---|
| PEG | -26.38 |
| Price to Sales | - |
| Price to Book Ratio | 1.8 |
| Enterprise Value to Revenue | 159.14 |
| Enterprise Value to EBIT | -1.37 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
ESG Score
No data
About Pliant Therapeutics Inc
CEO: Bernard Coulie